Tuesday’s market hints at U.S. economy if Iran war persists
Want to know what’s next for the economy if the U.S.-Iran war persists? CNBC’s Jim Cramer said Tuesday’s…
Trump prepares pharmaceutical tariffs of up to 100%
The Trump administration is preparing to impose new tariffs on branded drugs from pharmaceutical companies that have not…
Stocks soar on hopes of Iran war resolution — plus, Lilly takes a big swing in sleep disorders
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
Eli Lilly reaches deal to bring AI-developed drugs to global market
A drone view shows the Eli Lilly logo on the company’s office in San Diego, California, Nov. 21,…
Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline
Pharma giant Merck is buying U.S. biotech firm Terns Pharmaceuticals for $6.7 billion to boost its oncology pipeline,…
Pfizer Lyme disease vaccine fails trial, company to seek FDA approval
Thomas Fuller | Nurphoto | Getty Images Pfizer on Monday said it will seek regulatory approval for a…
Eli Lilly’s obesity drug retatrutide clears late-stage diabetes trial
The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike…
Icotyde psoriasis pill from J&J to rival Tremfya Skyrizi IL-23 shots
Signage outside Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025. Kyle Grillot |…
Novo Nordisk sues Hims & Hers over compounded obesity drugs
Novo Nordisk on Monday said it is suing online telehealth provider Hims & Hers for mass marketing cheaper,…